US Stock MarketDetailed Quotes

Healthcare Triangle (HCTI)

Watchlist
  • 2.390
  • -0.040-1.65%
Trading Jun 12 11:14 ET
4.85MMarket Cap-0.02P/E (TTM)

Healthcare Triangle (HCTI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
166.06%9.86M
18.77%13.89M
43.33%3.14M
44.59%3.49M
19.24%3.56M
-9.86%3.7M
-64.77%11.7M
-68.98%2.19M
-68.98%2.41M
-65.00%2.98M
Operating revenue
166.06%9.86M
18.77%13.89M
43.33%3.14M
44.59%3.49M
19.24%3.56M
-9.86%3.7M
-64.77%11.7M
-68.98%2.19M
-68.98%2.41M
-65.00%2.98M
Cost of revenue
121.10%7.46M
36.28%12M
39.14%2.69M
69.78%2.87M
46.88%3.06M
9.05%3.38M
-66.68%8.81M
-65.03%1.93M
-72.15%1.69M
-68.29%2.09M
Gross profit
627.36%2.39M
-34.60%1.89M
75.00%448K
-14.40%618K
-44.99%494K
-67.55%329K
-57.36%2.89M
-83.27%256K
-57.70%722K
-53.88%898K
Operating expense
241.11%5.89M
56.10%11.66M
734.59%4.87M
69.88%3.21M
-18.59%1.85M
-36.67%1.73M
-41.46%7.47M
-50.80%584K
-41.54%1.89M
-35.74%2.28M
Selling and administrative expenses
218.01%5M
69.36%10.42M
232.07%3.95M
126.62%3.11M
17.13%1.8M
-23.89%1.57M
-40.82%6.15M
-37.64%1.19M
-44.38%1.37M
-41.81%1.54M
-Selling and marketing expense
376.94%1.78M
39.99%3.08M
171.39%1.07M
247.62%1.02M
-2.38%616K
-57.76%373K
-52.83%2.2M
-49.49%395K
-73.30%294K
-38.50%631K
-General and administrative expense
168.53%3.22M
85.75%7.34M
262.30%2.87M
93.59%2.09M
30.75%1.18M
1.44%1.2M
-31.03%3.95M
-29.39%793K
-21.04%1.08M
-43.92%904K
Research and development costs
-40.97%85K
24.94%536K
448.75%279K
-66.29%59K
-73.43%55K
13.39%144K
-46.31%429K
-176.92%-80K
224.07%175K
102.94%207K
Depreciation amortization depletion
6,650.00%810K
-20.70%705K
220.23%630K
-81.63%63K
--0
-97.76%12K
-43.23%889K
36.25%-524K
-51.83%343K
-33.42%534K
-Depreciation and amortization
6,650.00%810K
-20.70%705K
220.23%630K
-81.63%63K
--0
-97.76%12K
-43.23%889K
36.25%-524K
-51.83%343K
-33.42%534K
Other operating expenses
----
----
----
---20K
----
----
----
----
----
----
Operating profit
-150.21%-3.5M
-113.32%-9.77M
-1,249.39%-4.43M
-122.02%-2.59M
1.38%-1.36M
18.39%-1.4M
23.46%-4.58M
-195.63%-328K
23.43%-1.17M
13.61%-1.38M
Net non-operating interest income expense
79.42%-85K
53.26%-567K
88.28%-100K
60.00%-32K
83.97%-21K
-177.18%-413K
-25.31%-1.21M
-179.67%-853K
80.72%-80K
29.57%-131K
Non-operating interest expense
-79.42%85K
-53.26%567K
-88.28%100K
-60.00%32K
-83.97%21K
177.18%413K
25.31%1.21M
179.67%853K
-80.72%80K
-29.57%131K
Other net income (expense)
-2,455.86%-2.62M
629.45%863K
23K
717K
13K
111K
90.40%-163K
Gain on sale of security
---63K
---18K
---4K
---14K
----
----
----
----
----
----
Special income (charges)
---125K
90.00%-17K
----
----
----
--0
90.06%-170K
----
----
----
-Less:Impairment of capital assets
----
----
----
----
----
----
--0
----
----
----
-Write off
--125K
-90.00%17K
----
----
----
--0
--170K
----
----
----
Other non- operating income (expenses)
-2,286.49%-2.43M
12,728.57%898K
--44K
--731K
--13K
--111K
-41.67%7K
----
----
----
Income before tax
-264.59%-6.2M
-59.07%-9.48M
-235.04%-4.5M
-52.85%-1.91M
9.34%-1.37M
8.70%-1.7M
31.14%-5.96M
19.62%-1.34M
35.69%-1.25M
15.27%-1.51M
Income tax
0
0
0
0
0
0
-65.71%12K
-42.86%4K
-50.00%2K
-80.00%1K
Net income
-264.59%-6.2M
-58.75%-9.48M
-234.05%-4.5M
-52.60%-1.91M
9.40%-1.37M
8.70%-1.7M
31.28%-5.97M
19.71%-1.35M
35.72%-1.25M
15.45%-1.51M
Net income continuous Operations
-264.59%-6.2M
-58.75%-9.48M
-234.05%-4.5M
-52.60%-1.91M
9.40%-1.37M
8.70%-1.7M
31.28%-5.97M
19.71%-1.35M
35.72%-1.25M
15.45%-1.51M
Minority interest income
Net income attributable to the parent company
-264.59%-6.2M
-58.75%-9.48M
-234.05%-4.5M
-52.60%-1.91M
9.40%-1.37M
8.70%-1.7M
31.28%-5.97M
19.71%-1.35M
35.72%-1.25M
15.45%-1.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-264.59%-6.2M
-58.75%-9.48M
-234.05%-4.5M
-52.60%-1.91M
9.40%-1.37M
8.70%-1.7M
31.28%-5.97M
19.71%-1.35M
35.72%-1.25M
15.45%-1.51M
Basic earnings per share
98.81%-6.6597
99.03%-152.3
99.11%-31.6164
99.22%-25.7348
99.14%-34.7953
90.47%-561.7978
47.78%-15.75K
38.99%-3.56K
51.49%-3.3K
35.52%-4.03K
Diluted earnings per share
98.81%-6.6597
99.03%-152.3
99.11%-31.6164
99.22%-25.7348
99.14%-34.7953
90.47%-561.7978
47.78%-15.75K
38.99%-3.56K
51.49%-3.3K
35.52%-4.03K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 166.06%9.86M18.77%13.89M43.33%3.14M44.59%3.49M19.24%3.56M-9.86%3.7M-64.77%11.7M-68.98%2.19M-68.98%2.41M-65.00%2.98M
Operating revenue 166.06%9.86M18.77%13.89M43.33%3.14M44.59%3.49M19.24%3.56M-9.86%3.7M-64.77%11.7M-68.98%2.19M-68.98%2.41M-65.00%2.98M
Cost of revenue 121.10%7.46M36.28%12M39.14%2.69M69.78%2.87M46.88%3.06M9.05%3.38M-66.68%8.81M-65.03%1.93M-72.15%1.69M-68.29%2.09M
Gross profit 627.36%2.39M-34.60%1.89M75.00%448K-14.40%618K-44.99%494K-67.55%329K-57.36%2.89M-83.27%256K-57.70%722K-53.88%898K
Operating expense 241.11%5.89M56.10%11.66M734.59%4.87M69.88%3.21M-18.59%1.85M-36.67%1.73M-41.46%7.47M-50.80%584K-41.54%1.89M-35.74%2.28M
Selling and administrative expenses 218.01%5M69.36%10.42M232.07%3.95M126.62%3.11M17.13%1.8M-23.89%1.57M-40.82%6.15M-37.64%1.19M-44.38%1.37M-41.81%1.54M
-Selling and marketing expense 376.94%1.78M39.99%3.08M171.39%1.07M247.62%1.02M-2.38%616K-57.76%373K-52.83%2.2M-49.49%395K-73.30%294K-38.50%631K
-General and administrative expense 168.53%3.22M85.75%7.34M262.30%2.87M93.59%2.09M30.75%1.18M1.44%1.2M-31.03%3.95M-29.39%793K-21.04%1.08M-43.92%904K
Research and development costs -40.97%85K24.94%536K448.75%279K-66.29%59K-73.43%55K13.39%144K-46.31%429K-176.92%-80K224.07%175K102.94%207K
Depreciation amortization depletion 6,650.00%810K-20.70%705K220.23%630K-81.63%63K--0-97.76%12K-43.23%889K36.25%-524K-51.83%343K-33.42%534K
-Depreciation and amortization 6,650.00%810K-20.70%705K220.23%630K-81.63%63K--0-97.76%12K-43.23%889K36.25%-524K-51.83%343K-33.42%534K
Other operating expenses ---------------20K------------------------
Operating profit -150.21%-3.5M-113.32%-9.77M-1,249.39%-4.43M-122.02%-2.59M1.38%-1.36M18.39%-1.4M23.46%-4.58M-195.63%-328K23.43%-1.17M13.61%-1.38M
Net non-operating interest income expense 79.42%-85K53.26%-567K88.28%-100K60.00%-32K83.97%-21K-177.18%-413K-25.31%-1.21M-179.67%-853K80.72%-80K29.57%-131K
Non-operating interest expense -79.42%85K-53.26%567K-88.28%100K-60.00%32K-83.97%21K177.18%413K25.31%1.21M179.67%853K-80.72%80K-29.57%131K
Other net income (expense) -2,455.86%-2.62M629.45%863K23K717K13K111K90.40%-163K
Gain on sale of security ---63K---18K---4K---14K------------------------
Special income (charges) ---125K90.00%-17K--------------090.06%-170K------------
-Less:Impairment of capital assets --------------------------0------------
-Write off --125K-90.00%17K--------------0--170K------------
Other non- operating income (expenses) -2,286.49%-2.43M12,728.57%898K--44K--731K--13K--111K-41.67%7K------------
Income before tax -264.59%-6.2M-59.07%-9.48M-235.04%-4.5M-52.85%-1.91M9.34%-1.37M8.70%-1.7M31.14%-5.96M19.62%-1.34M35.69%-1.25M15.27%-1.51M
Income tax 000000-65.71%12K-42.86%4K-50.00%2K-80.00%1K
Net income -264.59%-6.2M-58.75%-9.48M-234.05%-4.5M-52.60%-1.91M9.40%-1.37M8.70%-1.7M31.28%-5.97M19.71%-1.35M35.72%-1.25M15.45%-1.51M
Net income continuous Operations -264.59%-6.2M-58.75%-9.48M-234.05%-4.5M-52.60%-1.91M9.40%-1.37M8.70%-1.7M31.28%-5.97M19.71%-1.35M35.72%-1.25M15.45%-1.51M
Minority interest income
Net income attributable to the parent company -264.59%-6.2M-58.75%-9.48M-234.05%-4.5M-52.60%-1.91M9.40%-1.37M8.70%-1.7M31.28%-5.97M19.71%-1.35M35.72%-1.25M15.45%-1.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -264.59%-6.2M-58.75%-9.48M-234.05%-4.5M-52.60%-1.91M9.40%-1.37M8.70%-1.7M31.28%-5.97M19.71%-1.35M35.72%-1.25M15.45%-1.51M
Basic earnings per share 98.81%-6.659799.03%-152.399.11%-31.616499.22%-25.734899.14%-34.795390.47%-561.797847.78%-15.75K38.99%-3.56K51.49%-3.3K35.52%-4.03K
Diluted earnings per share 98.81%-6.659799.03%-152.399.11%-31.616499.22%-25.734899.14%-34.795390.47%-561.797847.78%-15.75K38.99%-3.56K51.49%-3.3K35.52%-4.03K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More